Nova Biomedical Recalls StatStrip Glucose Meters Due to Software Defect
Nova Biomedical is recalling StatStrip Glucose and B-Ketone meters due to a software defect that may cause patient data to be assigned to the wrong medical record.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which meets the rubric criteria for a Critical severity score due to the potential for serious adverse health consequences or death.
Plain-English summary
Nova Biomedical Corporation is recalling 8,939 units of the StatStrip Glucose and B-Ketone meter, Model No. 63910. The recall covers devices distributed worldwide, including the United States and 22 foreign countries. The affected software versions range from 0.00.13.10 through 1.5.14.25.
The recall is due to a software synchronization and timing issue in the barcode scanning and patient data processing component. This defect can cause the device to intermittently retain a previously scanned barcode, including patient identification and quality control barcodes, when a new barcode is scanned. As a result, the prior barcode information may remain displayed on the screen for the current test. If an operator accepts this incorrectly displayed information, the current patient's glucose result may be assigned to the previous patient's medical record, while the current patient's record remains without a result. This can lead to inappropriate clinical interventions based on erroneous data, particularly for critically ill patients, neonates, and infants. The defect does not affect the analytical accuracy of the glucose measurements themselves.
Healthcare facilities and users should stop using the affected devices and contact Nova Biomedical Corporation for instructions on how to proceed. The recall is classified as Class I by the FDA, indicating a reasonable probability that the use of, or exposure to, the violative product will cause serious adverse health consequences or death.
The recalled product
- Product
- StatStrip Glucose and B- Ketone meter. Model No: 63910. Glucose test system.
- Manufacturer
- Nova Biomedical Corporation
- Category
- Medical Device — Glucose Meter
- Affected units
- 8,939
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Nova Biomedical Corporation
See all →- SevereNova Biomedical StatStrip Glucose Meter Recalled for Data Error
FDA (Devices) · 2026-09-23
- CriticalNova StatStrip Glucose Hospital Meter System Recalled for Software Defect
FDA (Devices) · 2026-09-23
- SevereNova Biomedical Recalls StatStrip Glucose Meters Due to Software Defect
FDA (Devices) · 2026-09-23
- SevereNova Biomedical StatStrip Glucose Hospital Meter System Recalled for Software Defect
FDA (Devices) · 2026-09-23
- SevereBlood Glucose Ketone Meter Firmware Bug Causes Inaccurate Test Results
FDA (Devices) · 2025-01-01
Same hazard · data integrity
See all →- ModerateNatus Medical Recalls Embletta MPR PG Sleep Monitors Due to Memory Formatting Issues
FDA (Devices) · 2026-11-11
- ModeratePhilips Ingenia Blue Seal MRI Systems Recalled for DTI Export Errors
FDA (Devices) · 2026-10-07
- ModeratePhilips SmartPath to MR 7700 Recalled for Incorrect DTI Export Data
FDA (Devices) · 2026-10-07
- ModeratePhilips MR 7700 Software Upgrade Recalled for Incorrect DTI Data
FDA (Devices) · 2026-10-07
- ModeratePhilips MR 5300 Recalled for Incorrect Diffusion Tensor Imaging Data
FDA (Devices) · 2026-10-07
Similar recalls
- SevereNova Biomedical Recalls StatStrip Glucose Meters Due to Software Defect
FDA (Devices) · 2026-09-23
- SevereNova Biomedical StatStrip Glucose Meter Recalled for Data Error
FDA (Devices) · 2026-09-23
- SevereNova Biomedical StatStrip Glucose Hospital Meter System Recalled for Software Defect
FDA (Devices) · 2026-09-23
- CriticalNova StatStrip Glucose Hospital Meter System Recalled for Software Defect
FDA (Devices) · 2026-09-23
- SevereBlood Glucose Ketone Meter Firmware Bug Causes Inaccurate Test Results
FDA (Devices) · 2025-01-01
- SevereBlood glucose ketone meter software bug causes erroneous result transmission
FDA (Devices) · 2025-01-01